News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Isis Pharmaceuticals, Inc. (ISIS) (JOBS) Cholesterol Drug Meets All Goals of Key Trial


11/17/2009 8:31:13 AM

Bookmark and Share

Reuters -- An experimental drug for patients genetically disposed to extreme high cholesterol being developed by Isis Pharmaceuticals Inc (ISIS.O) and Genzyme Corp(GENZ.O) significantly lowered cholesterol in a pivotal late-stage study, according to data presented on Tuesday.

Read at Reuters

comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES